Compounds > lysine
Page last updated: 2024-08-17

lysine and B-Cell Chronic Lymphocytic Leukemia

lysine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Abruzzo, LV; Altmüller, J; Aszyk, C; Bloehdorn, J; Bruns, CJ; Coombes, KR; Dalvi, PS; Ecker, R; Elenitoba-Johnson, K; Fischer, K; Gathof, B; Grotenhuijs, F; Hallek, M; Herling, CD; Herling, M; Jebaraj, B; Jiang, Q; Kleppe, M; Mayer, P; Müller, T; Odenthal, M; Onder, O; Pacholewska, A; Persigehl, T; Plosnita, B; Rienhoff, HY; Robrecht, S; Schweiger, MR; Stachelscheid, J; Stilgenbauer, S; Vasyutina, E; Wagle, P; Wang, Z; Zhao, Y1
Gribben, JG1
Bravo-Navas, S; Briz, M; Domínguez-García, JJ; Pipaón, C; Romón, Í; Yáñez, L1
Brugat, T; Chevillard, S; Delic, J; Gault, N; Kruhoffer, M; Marteau, JB; Merle-Beral, H; Nguyen-Khac, F; Orntoft, TF; Rigaud, O; Vallat, L1
Aron, JL; Byrd, JC; Davis, ME; Grever, MR; Kanakry, C; Kitada, S; Lucas, DM; Marcucci, G; Mone, AP; Murphy, T; Parthun, MR; Reed, JC; Shen, T; Wickham, J1

Other Studies

5 other study(ies) available for lysine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia.
    Blood, 2023, Jul-06, Volume: 142, Issue:1

    Topics: Animals; Histone Demethylases; Histones; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lysine; Mice; Prospective Studies; Tumor Microenvironment

2023
Targeting the methylome to improve CLL outcome.
    Blood, 2023, Jul-06, Volume: 142, Issue:1

    Topics: Epigenome; Histone Demethylases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lysine

2023
Map of ubiquitin-like post-translational modifications in chronic lymphocytic leukemia. Role of p53 lysine 120 NEDDylation.
    Leukemia, 2021, Volume: 35, Issue:12

    Topics: Cells, Cultured; Cyclopentanes; Enzyme Inhibitors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lysine; Mass Spectrometry; NEDD8 Protein; Protein Processing, Post-Translational; Pyrimidines; Tumor Suppressor Protein p53; Ubiquitins

2021
Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.
    BMC medical genomics, 2010, Nov-10, Volume: 3

    Topics: Aged; Aged, 80 and over; Apoptosis; Case-Control Studies; DNA Methylation; Down-Regulation; Female; Gene Expression Profiling; Gene Silencing; Heterochromatin; Histones; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lysine; Male; Middle Aged; Promoter Regions, Genetic; Sex Characteristics; Transcription Factor RelB

2010
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.
    Blood, 2003, Jul-15, Volume: 102, Issue:2

    Topics: Acetylation; Apoptosis; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase 9; Caspases; Depsipeptides; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Histone Deacetylase Inhibitors; Histones; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Lysine; Neoplasm Proteins; Peptides, Cyclic; Protein Processing, Post-Translational; Tumor Cells, Cultured

2003